TRDA

TRDA R&D Expenses

$140.74MTTM · USD

Period ending:

TRDA FY R&D ExpensesUSD
TRDA FY R&D Expenses2019-12-31: $8.22M2020-12-31: $21.10M2021-12-31: $35.93M2022-12-31: $66.61M2023-12-31: $99.88M2024-12-31: $125.31M2025-12-31: $142.27M$142.27M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TRDA r&d expenses history

Research and development spending. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Entrada Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
142,269,000
125,306,000
99,884,000
66,609,000
35,926,000
21,102,000
8,216,000

Compare r&d expenses

All TRDA financial metrics · TRDA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.